Despite the fact that c-KIT mutation occurred at a lower incidence than BRAF and NRAS genes in most of the melanoma patients, it represented 36% of acral lentiginous melanomas in cutaneous melanoma (Ponti et al., 2017). This evidence concerns the gene KIT and acral lentiginous melanoma.